The expression of METTL6, a tumor-associated gene (TRG), is strongly correlated with the prognosis of patients with HCC and can serve as a potential prognostic indicator, providing new directions for the treatment strategies of patients with HCC [113] (Fig. 3). This evidence concerns the gene METTL6 and hepatocellular carcinoma.